Jan 4 • 48M

Ep. 34 - How to reform the orphan drug market

The FLATLINING Podcast

 
1×
0:00
-48:20
Open in playerListen on);
    Substack App
    Download MP3
    Get a private RSS link for listening
    Subscribe to The FLATLINING Podcast to get a private link for listening in your favorite podcast player. Learn about RSS.

Appears in this episode

Matthew Handley
Ron Howrigon
The FLATLINING Podcast brings you great healthcare analysis and discussion each week from industry experts who know their way around politics, economics, and a doctors office. Subscribe for more great content and check out the articles at www.FLATLINING.net.
Episode details
Comments
white blue and orange medication pill
Photo by Myriam Zilles on Unsplash

This week on the FLATLINING Podcast, Matthew and Ron take on the money-related topics of medical debt and orphan drugs. Who does medical debt hurt more: patients or providers? Is Medicare for All or single payor healthcare the solution to medical debt?

Drug companies make billions on orphan drugs, meant for a small number of people with very serious illnesses. Is this ethical? What was the purpose of the Orphan Drug Act? How can the drug market be reformed?

Ron and Matthew take on all of these topics on this week’s episode of the FLATLINING Podcast.

Happy new year everyone!

Join the conversation in our chat!

Join Fulcrum Strategies’s subscriber chat
Available in the Substack app and on web

Subscribe to the FLATLINING Podcast on Apple Podcasts, Spotify, the iHeartRadio app, Amazon Music, Google Podcasts, Stitcher, Pandora, and Audible.

The FLATLINING Podcast is now available on TuneIn!

Share

Articles mentioned in this program:

Hundreds of Hospitals Sue Patients or Threaten Their Credit, a KHN Investigation Finds. Does Yours? - Kaiser Health News

Life-saving treatments, blockbuster profits - WORLD Magazine

Nonprofit healthcare will likely take years to recover, S&P says - Becker’s Hospital Review

Share